Parameter | Estimated from | |
---|---|---|
Final covariate model (RSE) | Bootstrap 95 % CI | |
Pharmacokinetic parametera | ||
MTT (h) | 0.773 (43.1) | 0.809–2.38 |
CLCQ/F (L/h) | 6.13 (3.40) | 5.74–6.55 |
VC CQ/F (L) | 468 (16.0) | 137–529 |
VP CQ/F (L) | 1600 (5.21) | 1470–1800 |
QCQ/F (L/h) | 37.7 (18.9) | 31.1–69.0 |
t1/2 CQ (days) | 10.7 | |
CLDCQ/F (L/h) | 2.04 (3.50) | 1.90–2.18 |
VC DCQ/F (L) | 2.27 (14.1) | 1.62–2.90 |
VP DCQ/F (L) | 566,257 (14.4) | 198–341 |
QDCQ/F (L/h) | 31.46 (12.3) | 1.11–1.83 |
t1/2 DCQ (days) | 8.74 | |
Interindividual variabilityb | ||
BSV VC DCQ | 48.7 (47.5) | 17.9–71.1 |
BSV VP CQ | 20.0 (61.6) | 8.25–31.9 |
BSV VP DCQ | 86.8 (30.5) | 49.1–116 |
BSV F | 19.4 (31.7) | 13.1–25.4 |
Residual variabilityc | ||
Proportional error CQ | 0.401 (5.34) | 0.360–0.444 |
Proporional error DCQ | 0.431 (4.97) | 0.393–0.479 |